Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
umbilical cord-derived mesenchymal stem cells (Vinmec Research Institute of Stem Cell and Gene Technology)
- Development stage
- Unknown
- Lead developer
- Vinmec Research Institute of Stem Cell and Gene Technology
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intra-arterial
01
Overview
Investigational allogeneic cell therapy consisting of mesenchymal stem cells derived from umbilical cord tissue (UC-MSCs). Developed by the Vinmec Research Institute of Stem Cell and Gene Technology, this therapy is specifically being evaluated for the treatment of liver cirrhosis in pediatric patients with biliary atresia who have previously undergone a Kasai operation. The cells are administered via hepatic artery infusion to directly target the liver. The mechanism of action involves the immunomodulatory, anti-fibrotic, and regenerative properties of the stem cells, which aim to reduce hepatic fibrosis, improve liver function (as measured by PELD scores), and potentially delay or eliminate the need for liver transplantation.
- Other names
- UC-MSCsUmbilical Cord Derived Mesenchymal Stem Cell Transplantation
Beyond the preview
Go deeper on umbilical cord-derived mesenchymal stem cells (Vinmec Research Institute of Stem Cell and Gene Technology).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on umbilical cord-derived mesenchymal stem cells (Vinmec Research Institute of Stem Cell and Gene Technology).